anthralin has been researched along with Dermatitis, Irritant in 6 studies
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.
Dermatitis, Irritant: A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 6.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| "Anthralin was applied to psoriatic plaques on one side in the following fashion: anthralin 0." | 2.69 | A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. ( Dutz, JP; Lui, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Valk, PG | 2 |
| Zarafonitis, G | 1 |
| Snater, E | 1 |
| Healy, E | 1 |
| Reynolds, NJ | 1 |
| Smith, MD | 1 |
| Campbell, C | 1 |
| Farr, PM | 1 |
| Rees, JL | 1 |
| Schiavi, ME | 1 |
| Belletti, B | 1 |
| Seidenari, S | 1 |
| Dutz, JP | 1 |
| Lui, H | 1 |
| Prins, M | 1 |
| Swinkels, OQ | 1 |
| Mommers, JM | 1 |
| Gerritsen, MJ | 1 |
| Fluhr, JW | 1 |
| Kuss, O | 1 |
| Diepgen, T | 1 |
| Lazzerini, S | 1 |
| Pelosi, A | 1 |
| Gloor, M | 1 |
| Berardesca, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp Oil in the Hydration and Erythema of the Skin[NCT04045314] | 49 participants (Actual) | Interventional | 2019-08-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for anthralin and Dermatitis, Irritant
| Article | Year |
|---|---|
A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ambulatory Care Facilities; Anthralin; Anti-Inflam | 1998 |
5 other studies available for anthralin and Dermatitis, Irritant
| Article | Year |
|---|---|
Quantification of biophysical properties of the skin.
Topics: Anthralin; Biophysical Phenomena; Biophysics; Body Water; Dermatitis, Irritant; Erythema; Humans; Sk | 1995 |
Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants.
Topics: Adult; Aged; Aged, 80 and over; Anthralin; Dermatitis, Irritant; Erythema; Female; Gene Expression R | 1994 |
Ultrasound description and quantification of irritant reactions induced by dithranol at different concentrations. A comparison with visual assessment and colorimetric measurements.
Topics: Administration, Topical; Adolescent; Adult; Analysis of Variance; Anthralin; Anti-Inflammatory Agent | 1996 |
Dithranol treatment of psoriasis in dithranol-sensitive patients.
Topics: Administration, Topical; Adult; Anthralin; Anti-Inflammatory Agents; Dermatitis, Allergic Contact; D | 1999 |
Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types.
Topics: Adult; Analysis of Variance; Anthralin; Calorimetry; Dermatitis, Irritant; Erythema; Female; Humans; | 2001 |